![](/images/graphics-bg.png)
Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection
Joint Authors
Kuo, Fu-Chen
Hu, Chi-Tan
Wu, Meng-Chieh
Wu, I-Chen
Jheng, Guang-Hong
Bair, Ming-Jong
Hu, Huang-Ming
Hsu, Wen-Hung
Liu, Chung-Jung
Kuo, Chao-Hung
Shih, Hsiang-Yao
Hsu, Ping-I
Wu, Deng-Chyang
Source
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-6, 6 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-05-18
Country of Publication
Egypt
No. of Pages
6
Main Subjects
Abstract EN
The bismuth-based quadruple regimen has been applied in Helicobacter pylori rescue therapy worldwide.
The non-bismuth-based quadruple therapy or “concomitant therapy” is an alternative option in first-line eradication but has not been used in second-line therapy.
Discovering a valid regimen for rescue therapy in bismuth-unavailable countries is important.
We conducted a randomized controlled trial to compare the efficacies of the standard quadruple therapy and a modified concomitant regimen.
One hundred and twenty-four patients were randomly assigned into two groups: RBTM (rabeprozole 20 mg bid., bismuth subcitrate 120 mg qid, tetracycline 500 mg qid, and metronidazole 250 mg qid) and RATM (rabeprozole 20 mg bid., amoxicillin 1 g bid., tetracycline 500 mg qid, and metronidazole 250 mg qid) for 10 days.
The eradication rate of the RBTM and RATM regimen was 92.1% and 90.2%, respectively, in intention-to-treat analysis.
Patients in both groups had good compliance (~96%).
The overall incidence of adverse events was higher in the RATM group (42.6% versus 22.2%, P = 0.02 ), but only seven patients (11.5%) experienced grades 2-3 events.
In conclusion, both regimens had good efficacy, compliance, and acceptable side effects.
The 10-day RATM treatment could be an alternative rescue therapy in bismuth-unavailable countries.
American Psychological Association (APA)
Jheng, Guang-Hong& Wu, I-Chen& Shih, Hsiang-Yao& Wu, Meng-Chieh& Kuo, Fu-Chen& Hu, Huang-Ming…[et al.]. 2015. Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection. BioMed Research International،Vol. 2015, no. 2015, pp.1-6.
https://search.emarefa.net/detail/BIM-1054429
Modern Language Association (MLA)
Jheng, Guang-Hong…[et al.]. Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection. BioMed Research International No. 2015 (2015), pp.1-6.
https://search.emarefa.net/detail/BIM-1054429
American Medical Association (AMA)
Jheng, Guang-Hong& Wu, I-Chen& Shih, Hsiang-Yao& Wu, Meng-Chieh& Kuo, Fu-Chen& Hu, Huang-Ming…[et al.]. Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection. BioMed Research International. 2015. Vol. 2015, no. 2015, pp.1-6.
https://search.emarefa.net/detail/BIM-1054429
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1054429